Asia
It was a relatively quiet week for clinical trial news. Here’s a look.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 21, 2020.
Takeda continues to divest its over-the-counter business operations and has struck a deal for its U.S. offerings with The Blackstone Group, a U.S.-based investment fund valued at $2.37 billion.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 19, 2020.
It was a very busy week for clinical trial updates. Here’s a look.
A COVID-19 vaccine candidate developed by Chinese pharmaceutical company Sinopharm triggered antibody-based immune responses in early and mid-stage trials.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 14, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 10, 2020.
Novavax said the agreement will allow for the development and distribution of NVX‑CoV2373, a recombinant vaccine engineered from the genetic sequence of SARS-CoV-2, in India and in low- and middle-income countries.
PRESS RELEASES